Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Beginning to think Jonah was right about LordTopUp and his subtle de-ramping. Funny how they all come out when the SP is dropping. If you are genuine, LTU, then the bombing share price should answer your initial question and you should steer clear.
Now I know you haven’t done your research
That's Mr Lamb, PATTSV, another major shareholder. You need to practice what you preach regarding research!
Can someone tell me who Mr Adams is, please?
You are asking ? you already know.You have come on this site for ??????
Thanks for your answer, PATTSV. But isn't this cutting it fine? It seems the MHRA gave FUM a year to respond last February, so if nothing happens in the next few weeks the Thornton submission will have expired!
Crikey. Link removed!
Moving on to TPR. Why is it taking a year to answer the questions from the MHRA?
It's OK guys. Got it:
https://futuramedical.com/what-we-do/med2005/med2005-overview/
Haha maybe keep your few grand!!!
"Forget MED, it's dead"
-----------------------------------------------
I HAVE done some research and MED is NOT dead according to FUM's very own website! Look:
Sorry. Trying to post the website link but the site appears to be down!
Lord Topup
Mr Adams: refer to Jonah's post of Wednesday and previous posts re Mr Adam's
identity
Hi Mr Lord,
Well if you are not going to invest on who holds what maybe you should do some more research on your own.Maybe if you new who is was you may??
I’m not touchy just you have come on saying not a great website=poor management so that’s fair as we can all have a view.Im sure we can make our minds up to invest or not so maybe this share isn’t for you either way good luck
Hi Jonah, I'm not deliberately slating anyone I'm just voicing some concerns. Very touchy on here!
Who is Mr Adams? I know he has a large stake in FUM but then again there's millions of more people who don't so I wouldn't base my investment decision on who holds and who doesn't!
I can see clear trials for MED but not dermasys, PATTSV. And what if further trials are indeed required for dermasys and MED is used as the placebo which will give a high placebo response therefore a failed trial? It's all very confusing!
Mr lord,
You have come in to slate the board and de ramp the S/p good luck.
I’m sure Mr Adams is taking your advice??
Thanks for your advice, colmcq. Silly me, I should have checked the RNSs but my first port of call is usually the website rather than reading reams of RNSs. A badly maintained website is poor management and also misleading.
Checking out the dermasys product, even though it formed part pf the MED trials it wasn't the lead product being tested so I'll be surprised if the regulators didn't demand a formal complete trial (especially the FDA), albeit a simpler pathway than MED, but still necessary taking a few years. Which begs the question - was the recent fund raise short term survival rather than long term investment?
Avoid
They failed phase 3 trails and are attempting to flog their placebo from the trial as a product.
I bought in just before phase 3 results but I'm holding on for long term desperation
This stock is an utter donkey
I'm looking to invest a few grand in some bio-tecs and I'm interested in FUM's lead product MED. It says on their website they expected trial results before the end of 2019. Has anyone any idea when they might be released?